These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 25126141)
1. Pattern of adverse drug reactions reported by the community pharmacists in Nepal. Palaian S; Ibrahim MI; Mishra P Pharm Pract (Granada); 2010 Jul; 8(3):201-7. PubMed ID: 25126141 [TBL] [Abstract][Full Text] [Related]
2. An evaluation of knowledge, attitude and practice of Indian pharmacists towards adverse drug reaction reporting: A pilot study. Ahmad A; Patel I; Balkrishnan R; Mohanta GP; Manna PK Perspect Clin Res; 2013 Oct; 4(4):204-10. PubMed ID: 24312887 [TBL] [Abstract][Full Text] [Related]
3. Medication safety knowledge, attitudes and practices among community pharmacists in Lebanon. Hajj A; Hallit S; Ramia E; Salameh P; Curr Med Res Opin; 2018 Jan; 34(1):149-156. PubMed ID: 28758813 [TBL] [Abstract][Full Text] [Related]
4. Community pharmacists' knowledge and perspectives of reporting adverse drug reactions in Australia: a cross-sectional survey. Li R; Curtain C; Bereznicki L; Zaidi STR Int J Clin Pharm; 2018 Aug; 40(4):878-889. PubMed ID: 30097819 [TBL] [Abstract][Full Text] [Related]
5. A national survey of knowledge, attitude, practice, and barriers towards pharmacovigilance and adverse drug reaction reporting among hospital pharmacy practitioners in the United Arab Emirates. Shanableh S; Zainal H; Alomar M; Palaian S J Pharm Policy Pract; 2023 Jul; 16(1):92. PubMed ID: 37464445 [TBL] [Abstract][Full Text] [Related]
6. Medication safety knowledge, attitude, and practice among hospital pharmacists in tertiary care hospitals in Saudi Arabia: a multi-center study. Al-Mutairi A; AlFayyad I; Altannir Y; Al-Tannir M Arch Public Health; 2021 Jul; 79(1):130. PubMed ID: 34253257 [TBL] [Abstract][Full Text] [Related]
7. A survey on factors that could affect adverse drug reaction reporting according to hospital pharmacists in Great Britain. Sweis D; Wong IC Drug Saf; 2000 Aug; 23(2):165-72. PubMed ID: 10945377 [TBL] [Abstract][Full Text] [Related]
8. Barriers to reporting of adverse drugs reactions: a cross sectional study among community pharmacists in United Kingdom. Cheema E; Haseeb A; Khan TM; Sutcliffe P; Singer DR Pharm Pract (Granada); 2017; 15(3):931. PubMed ID: 28943977 [TBL] [Abstract][Full Text] [Related]
9. Starting a pharmacovigilance program within a teaching hospital: Challenges and experiences from Lalitpur, Nepal. Jha N; Bajracharya O; Shrestha R; Thapa HS; Shankar PR South Med Rev; 2009 Apr; 2(1):7-10. PubMed ID: 23093871 [TBL] [Abstract][Full Text] [Related]
10. Factors that facilitate reporting of adverse drug reactions by pharmacists in Saudi Arabia. Aldryhim AY; Alomair A; Alqhtani M; Mahmoud MA; Alshammari TM; Pont LG; Kamal KM; Aljadhey H; Mekonnen AB; Alwhaibi M; Balkhi B; Alhawassi TM Expert Opin Drug Saf; 2019 Aug; 18(8):745-752. PubMed ID: 31232612 [No Abstract] [Full Text] [Related]
11. Evaluation of Knowledge, Attitudes, and Practices about Pharmacovigilance among Community Pharmacists in Qassim, Saudi Arabia. Abdulsalim S; Farooqui M; Alshammari MS; Alotaibi M; Alhazmi A; Alqasomi A; Altowayan WM Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36834240 [TBL] [Abstract][Full Text] [Related]
12. The knowledge and attitude of the Turkish community pharmacists toward pharmacovigilance in the Kadikoy district of Istanbul. Toklu HZ; Uysal MK Pharm World Sci; 2008 Oct; 30(5):556-62. PubMed ID: 18350373 [TBL] [Abstract][Full Text] [Related]
13. Pharmacovigilance and adverse drug reaction reporting: a perspective of community pharmacists and pharmacy technicians in Sana'a, Yemen. Al-Worafi YM; Kassab YW; Alseragi WM; Almutairi MS; Ahmed A; Ming LC; Alkhoshaiban AS; Hadi MA Ther Clin Risk Manag; 2017; 13():1175-1181. PubMed ID: 28924350 [TBL] [Abstract][Full Text] [Related]
14. Safety of medicines-Pharmacists' knowledge, practice, and attitudes toward pharmacovigilance and adverse drug reactions reporting process. Kopciuch D; Zaprutko T; Paczkowska A; Ratajczak P; Zielińska-Tomczak Ł; Kus K; Nowakowska E Pharmacoepidemiol Drug Saf; 2019 Dec; 28(12):1543-1551. PubMed ID: 31148344 [TBL] [Abstract][Full Text] [Related]
15. Medication safety knowledge, attitude, and practice among hospital pharmacists in Lebanon. Hallit S; Hajj A; Shuhaiber P; Iskandar K; Ramia E; Sacre H; Salameh P; J Eval Clin Pract; 2019 Apr; 25(2):323-339. PubMed ID: 30592116 [TBL] [Abstract][Full Text] [Related]
16. Exploring healthcare professionals' knowledge, attitude, and practices towards pharmacovigilance: a cross-sectional survey. Hussain R; Hassali MA; Hashmi F; Akram T J Pharm Policy Pract; 2021 Jan; 14(1):5. PubMed ID: 33397478 [TBL] [Abstract][Full Text] [Related]
17. A cross sectional pilot study on assessing the knowledge, attitude and behavior of community pharmacists to adverse drug reaction related aspects in the Sultanate of Oman. Jose J; Jimmy B; Al-Ghailani AS; Al Majali MA Saudi Pharm J; 2014 Apr; 22(2):163-9. PubMed ID: 24648829 [TBL] [Abstract][Full Text] [Related]
18. Factors that influence under-reporting of suspected adverse drug reactions among community pharmacists in a Spanish region. Irujo M; Beitia G; Bes-Rastrollo M; Figueiras A; Hernández-Díaz S; Lasheras B Drug Saf; 2007; 30(11):1073-82. PubMed ID: 17973543 [TBL] [Abstract][Full Text] [Related]
19. ADVERSE DRUG REPORTING IN COMMUNITY PHARMACY PRACTICE IN THE POMERANIAN DISTRICT IN POLAND. Zimmermann A; Gaworska-Krzeminska A; Flis A Acta Pol Pharm; 2016 Sep; 73(5):1389-1396. PubMed ID: 29638080 [TBL] [Abstract][Full Text] [Related]
20. Knowledge, Attitude and Practice of Hospital Pharmacists in Central China Towards Adverse Drug Reaction Reporting: A Multicenter Cross-Sectional Study. Hu W; Tao Y; Lu Y; Gao S; Wang X; Li W; Jiang Q; Lin L; Sun F; Cheng H Front Pharmacol; 2022; 13():823944. PubMed ID: 35392558 [No Abstract] [Full Text] [Related] [Next] [New Search]